A synthetic palm oil manufacturer has raised US$20m in funding to scale its technology and prepare the business for commercial launch.
C16 Biosciences uses
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.